Talis Biomedical Corp
TLISDelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001584751
Talis Biomedical Corp was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Sep 9, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $6.84M in total; Greenlight Capital was the only superinvestor holding it.
Q1 2024 vs. Q4 2023
How the institutions holding Talis Biomedical Corp changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 18 | 1 | 18 | +1 |
| Shares | 796.6K | 149.1K | 792.5K | +145.0K (+22.4%) |
| Value | $5.93M | $1.11M | $6.93M | +$2.11M (+43.7%) |
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held Talis Biomedical Corp at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| DME Capital Management, LPSuperinvestorGreenlight Capital | 149,052 | $1.30M | 0.06% |
| Renaissance Technologies LLC | 10,299 | $90.0K | 0.00% |
| ADAR1 Capital Management, LLC | 300 | $2.63K | 0.00% |
Sold out (2)
Institutions that held Talis Biomedical Corp at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Citadel Advisors LLC | 10,024 | $74.7K |
| Citigroup Inc | 1,624 | $12.1K |
Not filed for Q1 2024 yet (1)
Institutions that held Talis Biomedical Corp at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Greenlight Capital Inc | 149,052 | $1.11M |